Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalculus Vct Regulatory News (CLC)

Share Price Information for Calculus Vct (CLC)

Share Price is delayed by 15 minutes
Get Live Data
53.25    0.00 (0.00%)
Bid:
48.00
Ask:
58.50
Spread: 10.50 (21.875%)
Market Cap: £51.93m
CLC Live PriceLast checked at - London Stock Exchange

Intraday Calculus Vct Share Chart

Directorate change

31 Mar 2026 17:55

RNS Number : 9332Y
Calculus VCT PLC
31 March 2026
 

CALCULUS VCT PLC (the Company or Calculus )LEI: 2138005SMDWLMMNPVA90

 

CHANGE IN DIRECTORSHIP

 

Calculus VCT plc announces that John Glencross has today retired from the Board of Directors.

 

The Board would like to express its sincere appreciation to John Glencross for his long and highly valued service. Although he is stepping down from the Board, John will continue to remain closely involved with the Company through his ongoing role as Chief Executive of Calculus Capital Limited ("Manager") , the Company's investment manager, ensuring continuity and continued alignment between the Board and the Manager.

 

The Company is delighted to confirm the appointment of Alexander Crawford as a Non‑Executive Director, effective 1 April 2026. Alexander, who joined Calculus Capital in 2015, now co‑heads the firm's investment team at the Manager and brings substantial expertise to the Board. His extensive transaction experience and long-standing involvement with Calculus will provide valuable insight and support to the Board as the Company continues to pursue its investment strategy.

 

There is no further information required to be disclosed under UK Listing Rule UKLR 6.4.8

 

 

Calculus Capital Limited

Company Secretary

Dated: 31 March 2026

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAJBMFTMTIJBLF
Date   Source Headline
22nd Sep 20231:03 pmRNSPublication of a Prospectus
21st Sep 20233:51 pmRNSAppointment of Auditor
7th Sep 20234:57 pmRNSTransaction in Own Shares
30th Aug 202311:28 amRNSStatement re Intention to Raise
25th Aug 20231:19 pmRNSIssue of Equity
21st Aug 20233:25 pmRNSAGM and GM Statement
21st Jul 202312:13 pmRNSIssue of Equity and Total Voting Rights
17th Jul 20233:04 pmRNSPublication of Circular and Notice of GM
3rd Jul 20235:43 pmRNSMay 2023 NAV Announcement
30th Jun 20232:15 pmRNSAnnual Financial Report & Change in Year-End date
5th Apr 20234:52 pmRNSIssue of Equity
5th Apr 20232:40 pmRNSIssue of Equity
15th Mar 20232:45 pmRNSIssue of Equity
9th Mar 20235:31 pmRNSTransaction in Own Shares
9th Mar 20237:00 amRNSTransaction in Own Shares
16th Dec 20223:41 pmRNSIssue of Equity
9th Dec 20225:06 pmRNSNet Asset Value(s)
18th Oct 202211:45 amRNSHalf-year Report
21st Sep 20222:34 pmRNSPublication of a Prospectus
31st Aug 20221:11 pmRNSIssue of Equity
29th Jul 202212:05 pmRNSTotal Voting Rights
14th Jul 20222:48 pmRNSRESULTS OF ANNUAL GENERAL MEETING
30th Jun 20222:03 pmRNSIssue of Equity
29th Jun 20222:37 pmRNSDirector Declaration
29th Jun 202211:45 amRNSNet Asset Value(s)
10th Jun 20225:12 pmRNSTransaction in Own Shares
1st Jun 20227:00 amRNSAnnual Financial Report
5th Apr 202212:23 pmRNSIssue of Equity
22nd Mar 20221:40 pmRNSIssue of Equity
1st Feb 20223:59 pmRNSNet Asset Value(s)
17th Dec 20211:08 pmRNSShare allotment and Total Voting Rights
12th Nov 20214:30 pmRNSTransaction in Own Shares
25th Oct 202112:00 pmRNSHalf yearly unaudited financial report
13th Sep 202112:12 pmRNSPublication of a Prospectus
2nd Sep 202110:30 amRNSIssue of Equity
6th Aug 20212:57 pmRNSChange of Registered Office
30th Jul 20211:18 pmRNSIssue of Equity
8th Jul 20215:07 pmRNSResult of Annual General Meeting
30th Jun 20213:38 pmRNSIssue of Equity and Total voting rights
17th Jun 202110:58 amRNSUnaudited Net Asset Value as at 31 May 2021
15th Jun 20219:18 amRNSCorrection to the AGM notice
21st May 20214:02 pmRNSCorrection to Dividend Record Date
21st May 20217:00 amRNSAnnual Financial Report
1st Apr 20214:06 pmRNSTotal Voting Rights
9th Mar 20213:24 pmRNSNet Asset Value 31 January 2021
23rd Feb 202110:14 amRNSTransaction in Own Shares
16th Dec 20205:35 pmRNSIssue of Equity and Total Voting Rights
15th Dec 202011:33 amRNSNet Asset Value(s)
23rd Oct 20201:31 pmRNSHalf-year Report
11th Sep 202012:03 pmRNSIssue of Equity - Amendment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.